[1]
I. Vynnychenko, L. Syvak, and R. Lakhtaryna, “Body mass index as a predictor of the efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer and other solid tumors”, Regul. Mech. Biosyst., vol. 17, no. 4, p. e26078, May 2026.